Oscar Talvitie

The Signet Collection was created in 2020 and has become acclaimed for its innovative reimagining of historic boutique hotels, creating meaningful and memorable stays. Our hotels have history, stories to tell. Each one of our hotels is imbued with generations of tales, legacies, myths and legends. We unearth this history, these stories. We restore, reimagine and pass them on for our guests to enjoy.

Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. Locus Biosciences has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria. Guided by the custom Locus Bio CRISPRs, the Type-I Cas proteins work to destroy bacterial DNA and cause the bacterial targets to “self-destruct”. Locus’ platform enables the development of antimicrobials which avoid currently known resistance mechanisms while leaving non-target bacteria unharmed. Built on prokaryotic technology for prokaryotic targets, Locus is advancing its platform to create therapeutics for critical-need therapeutic areas ranging from resistant bacterial infections to the microbiome.

Shapes AI enables machines to reason with what they see. Our award-winning 'Deep Visual Reasoning'​ technology analyses scenes to automatically flag pertinent activities and behaviours. With this unprecedented AI capability, we're shaping the future of video analytics. We've come together from Cambridge, Stanford, Princeton, Uber, Microsoft and beyond.

Mad Street Den® is a computer vision and artificial intelligence company, founded with a mission to make people all over the globe, A.I natives. The team’s mission is to build models of generalizable intelligence and create actionable ways to contextualize AI on scale, helping millions of people across the globe to become A.I native. The company’s first vertical, under its flagship brand, Vue.ai®, aims to bring this mission into the retail industry. The image and video recognition platform transforms traditional stores and online retail businesses with intelligent retail automation. Vue.ai® has succeeded in becoming one of the most well-known, value-driven retail A.I firms within the industry in a short span of 3 years. With the accelerated growth of its first vertical, the firm has now begun its expansion into other verticals including healthcare, education, finance, and more, inching closer to it’s bigger mission. Mad Street Den is funded by marquee investors, including Sequoia Capital and Falcon Edge Capital. With about $30M in funding and a star-studded AI team, we’re now looking to grow our organization across the globe rapidly and are hiring for the following positions. The company has over 220+ employees across the US, Japan, and India - and we’re still growing!

Delivering on our promise to identify any microbe, from any sample, anywhere in the world will take a team of dedicated, passionate, and experienced individuals. The members of our team at IDbyDNA have a strong track record of building successful organizations and bring a breadth of multi-disciplinary experience including; microbial genomics, bioinformatics, software engineering, laboratory medicine, and commercialization. In concert with the global community of researchers, clinicians, industry partners and policy makers, we will revolutionize microbial detection and bring new solutions to solve problems that are not currently addressable with today’s technologies.

Build the right thing. Faster.

Connecting the right people with the right wines, from 1854 onwards.

The Signet Collection was created in 2020 and has become acclaimed for its innovative reimagining of historic boutique hotels, creating meaningful and memorable stays. Our hotels have history, stories to tell. Each one of our hotels is imbued with generations of tales, legacies, myths and legends. We unearth this history, these stories. We restore, reimagine and pass them on for our guests to enjoy.

Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. Locus Biosciences has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria. Guided by the custom Locus Bio CRISPRs, the Type-I Cas proteins work to destroy bacterial DNA and cause the bacterial targets to “self-destruct”. Locus’ platform enables the development of antimicrobials which avoid currently known resistance mechanisms while leaving non-target bacteria unharmed. Built on prokaryotic technology for prokaryotic targets, Locus is advancing its platform to create therapeutics for critical-need therapeutic areas ranging from resistant bacterial infections to the microbiome.

Shapes AI enables machines to reason with what they see. Our award-winning 'Deep Visual Reasoning'​ technology analyses scenes to automatically flag pertinent activities and behaviours. With this unprecedented AI capability, we're shaping the future of video analytics. We've come together from Cambridge, Stanford, Princeton, Uber, Microsoft and beyond.